INNV (InnovAge Holding) Beta: 0.9453 (As of Jun. 25, 2026)


INNV InnovAge Holding Corp INNV
72 GF Score
Price $10.35
GF Value $6.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is InnovAge Holding Beta?

InnovAge Holding INNV +7.03% 72 Beta is 0.9453 as of Jun. 25, 2026. GuruFocus rates INNV with a GF Score™ of 72/100 and a GF Value™ of $6.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), InnovAge Holding's Beta is 0.9453.


InnovAge Holding  (NAS:INNV) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


InnovAge Holding Beta Related Terms


InnovAge Holding Beta Historical Data

* Premium members only.

The historical data trend for InnovAge Holding's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnovAge Holding Beta Chart

InnovAge Holding Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.38 -0.00

InnovAge Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 -0.00 1.12 1.45 1.16

INNV vs USPH, AMN, NUTX: Beta Comparison

For the Medical Care Facilities subindustry, InnovAge Holding's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovAge Holding Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Beta distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Beta falls into.


INNV
72GF Score
InnovAge Holding Corp INNV
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InnovAge Holding Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.9453 mean?
InnovAge Holding (INNV) has a Beta of 0.9453 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for InnovAge Holding and its competitors.
Is InnovAge Holding's Beta too high?
InnovAge Holding's current Beta is 0.9453. Overall, InnovAge Holding has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's Beta compare to USPH and AMN?
InnovAge Holding's Beta of 0.9453 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for InnovAge Holding and its competitors. InnovAge Holding's current Beta is 0.9453. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.52, compared to a current price of $10.35 — trading 58.7% above its estimated fair value. The current Beta is 0.9453. InnovAge Holding's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For InnovAge Holding (INNV), the current Beta is 0.9453 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InnovAge Holding (INNV) Overvalued in 2026?

Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued. The current stock price of $10.35 is trading 58.7% above its estimated GF Value™ of $6.52. GuruFocus considers InnovAge Holding to be Significantly Overvalued.

Key valuation signals for INNV:

  • Beta: 0.9453
  • GF Value™: $6.52 vs. price of $10.35 (58.7% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InnovAge Holding Business Description

Address 8950 East Lowry Boulevard, Denver, CO, USA, 80230
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
72GF Score

Get the complete analysis for INNV

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.35
Price
$6.52
GF Value